Conference Coverage

High level of psychiatric morbidity in prodromal MS 


 

AT ACTRIMS FORUM 2023

When does MS start?

Commenting on the research findings, Mark Freedman, MD, professor of medicine (Neurology), University of Ottawa, and director of the multiple sclerosis research unit, Ottawa Hospital-General Campus, said the study illustrates the increased research attention the interplay between MS and psychiatric disorders is getting.

He recalled “one of the most compelling” recent studies that looked at a large group of children with MS and showed their grades started falling more than 5 years before developing MS symptoms. “You could see their grades going down year by year by year, so an indicator that a young brain, which should be like a sponge and improving, was actually faltering well before the symptoms.”

Results from this new study continue to beg the question of when MS actually starts, said Dr. Freedman.

The study received funding from the U.S. National MS Society, the MS Society of Canada, and the Michael Smith Foundation. Dr. Chertcoff and Dr. Freedman reported no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Changing marijuana laws pose health challenges
MDedge Emergency Medicine
FDA investigating risk of gadolinium contrast agent brain deposits
MDedge Emergency Medicine
FDA: Gadolinium retention prompts new GBCA class warning, safety measures
MDedge Emergency Medicine
FDA: Gadolinium retention prompts new GBCA class warning, safety measures
MDedge Emergency Medicine
Can immune checkpoint inhibitors treat PML?
MDedge Emergency Medicine
Clinicians petition government for national quarantine
MDedge Emergency Medicine
Lessons for patients with MS and COVID-19
MDedge Emergency Medicine
NIH to study COVID vaccine booster in people with autoimmune disease
MDedge Emergency Medicine
Tastier chocolate may be healthier chocolate
MDedge Emergency Medicine